Cefepime: a novel cause of thrombocytopaenia

Thrombocytopaenia is a commonly encountered finding in hospitalised patients. Many antibiotics, especially beta-lactams, are well known to cause thrombocytopaenia by an immune-mediated mechanism. We present a 55-year-old woman who was admitted to the hospital with a complicated urinary tract infecti...

Full description

Saved in:
Bibliographic Details
Published in:BMJ case reports 2022-01, Vol.15 (1), p.e243749
Main Authors: Muhammad, Shoaib, Ahmad, Soban, Khan, Behram Ahmed, Yousaf, Amman
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - adverse effects
Antibiotics
Antibodies
Asymptomatic
Blood platelets
Blood tests
Case Report
Case reports
Cefepime - adverse effects
Creatinine
Female
Hepatitis
HIV
Human immunodeficiency virus
Humans
Laboratories
Middle Aged
Patients
Platelet Count
Thrombocytopenia
Thrombocytopenia - chemically induced
Thrombosis
Urinary Tract Infections
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c380t-3fe9feee927efdc5575c819eef3d93b7ee1ee42ce01cc4c5d6263600418c9cd03
cites cdi_FETCH-LOGICAL-c380t-3fe9feee927efdc5575c819eef3d93b7ee1ee42ce01cc4c5d6263600418c9cd03
container_end_page
container_issue 1
container_start_page e243749
container_title BMJ case reports
container_volume 15
creator Muhammad, Shoaib
Ahmad, Soban
Khan, Behram Ahmed
Yousaf, Amman
description Thrombocytopaenia is a commonly encountered finding in hospitalised patients. Many antibiotics, especially beta-lactams, are well known to cause thrombocytopaenia by an immune-mediated mechanism. We present a 55-year-old woman who was admitted to the hospital with a complicated urinary tract infection resulting in right-sided pyonephrosis and pararenal abscess. She was observed to develop thrombocytopaenia after initiation of cefepime therapy. Following an extensive work-up for her new-onset thrombocytopaenia, she was diagnosed as a case of a drug (cefepime)-induced thrombocytopaenia. Her platelet count recovered back to normal levels after cessation of cefepime therapy. Based on our PubMed search, there are only a few cases of cefepime-induced thrombocytopaenia published in the literature. This paper illustrates that physicians should include cefepime among the possible aetiologies of thrombocytopaenia. Additionally, this article outlines the currently available approaches to the diagnosis and management of drug-induced thrombocytopaenia.
doi_str_mv 10.1136/bcr-2021-243749
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8767964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2620245806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-3fe9feee927efdc5575c819eef3d93b7ee1ee42ce01cc4c5d6263600418c9cd03</originalsourceid><addsrcrecordid>eNpVkM1Lw0AQxRdRbKk9e5OAV2N3M5vdrAdBil9Q8KLgbdlsZm1Kk42bpND_3pRWqXOZgXnz5vEj5JLRW8ZAzHIb4oQmLE44SK5OyJjJVMZS0c_To3lEpm27okMB4xmHczKClIICkGNyM0eHTVnhXWSi2m9wHVnTtxh5F3XL4Kvc223nG4N1aS7ImTPrFqeHPiEfT4_v85d48fb8On9YxBYy2sXgUDlEVIlEV9g0lanNmEJ0UCjIJSJD5IlFyqzlNi1EIkBQyllmlS0oTMj93rfp8woLi3UXzFo3oaxM2GpvSv1_U5dL_eU3OpNCKsEHg-uDQfDfPbadXvk-1ENmnYgBGU8zKgbVbK-ywbdtQPf3gVG9I6wHwnpHWO8JDxdXx8H-9L884Qfqk3en</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620245806</pqid></control><display><type>article</type><title>Cefepime: a novel cause of thrombocytopaenia</title><source>PubMed (Medline)</source><creator>Muhammad, Shoaib ; Ahmad, Soban ; Khan, Behram Ahmed ; Yousaf, Amman</creator><creatorcontrib>Muhammad, Shoaib ; Ahmad, Soban ; Khan, Behram Ahmed ; Yousaf, Amman</creatorcontrib><description>Thrombocytopaenia is a commonly encountered finding in hospitalised patients. Many antibiotics, especially beta-lactams, are well known to cause thrombocytopaenia by an immune-mediated mechanism. We present a 55-year-old woman who was admitted to the hospital with a complicated urinary tract infection resulting in right-sided pyonephrosis and pararenal abscess. She was observed to develop thrombocytopaenia after initiation of cefepime therapy. Following an extensive work-up for her new-onset thrombocytopaenia, she was diagnosed as a case of a drug (cefepime)-induced thrombocytopaenia. Her platelet count recovered back to normal levels after cessation of cefepime therapy. Based on our PubMed search, there are only a few cases of cefepime-induced thrombocytopaenia published in the literature. This paper illustrates that physicians should include cefepime among the possible aetiologies of thrombocytopaenia. Additionally, this article outlines the currently available approaches to the diagnosis and management of drug-induced thrombocytopaenia.</description><identifier>ISSN: 1757-790X</identifier><identifier>EISSN: 1757-790X</identifier><identifier>DOI: 10.1136/bcr-2021-243749</identifier><identifier>PMID: 35039337</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Anti-Bacterial Agents - adverse effects ; Antibiotics ; Antibodies ; Asymptomatic ; Blood platelets ; Blood tests ; Case Report ; Case reports ; Cefepime - adverse effects ; Creatinine ; Female ; Hepatitis ; HIV ; Human immunodeficiency virus ; Humans ; Laboratories ; Middle Aged ; Patients ; Platelet Count ; Thrombocytopenia ; Thrombocytopenia - chemically induced ; Thrombosis ; Urinary Tract Infections</subject><ispartof>BMJ case reports, 2022-01, Vol.15 (1), p.e243749</ispartof><rights>BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2022 BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ. 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-3fe9feee927efdc5575c819eef3d93b7ee1ee42ce01cc4c5d6263600418c9cd03</citedby><cites>FETCH-LOGICAL-c380t-3fe9feee927efdc5575c819eef3d93b7ee1ee42ce01cc4c5d6263600418c9cd03</cites><orcidid>0000-0003-0646-508X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767964/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767964/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27900,27901,53765,53767</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35039337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muhammad, Shoaib</creatorcontrib><creatorcontrib>Ahmad, Soban</creatorcontrib><creatorcontrib>Khan, Behram Ahmed</creatorcontrib><creatorcontrib>Yousaf, Amman</creatorcontrib><title>Cefepime: a novel cause of thrombocytopaenia</title><title>BMJ case reports</title><addtitle>BMJ Case Rep</addtitle><description>Thrombocytopaenia is a commonly encountered finding in hospitalised patients. Many antibiotics, especially beta-lactams, are well known to cause thrombocytopaenia by an immune-mediated mechanism. We present a 55-year-old woman who was admitted to the hospital with a complicated urinary tract infection resulting in right-sided pyonephrosis and pararenal abscess. She was observed to develop thrombocytopaenia after initiation of cefepime therapy. Following an extensive work-up for her new-onset thrombocytopaenia, she was diagnosed as a case of a drug (cefepime)-induced thrombocytopaenia. Her platelet count recovered back to normal levels after cessation of cefepime therapy. Based on our PubMed search, there are only a few cases of cefepime-induced thrombocytopaenia published in the literature. This paper illustrates that physicians should include cefepime among the possible aetiologies of thrombocytopaenia. Additionally, this article outlines the currently available approaches to the diagnosis and management of drug-induced thrombocytopaenia.</description><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Antibiotics</subject><subject>Antibodies</subject><subject>Asymptomatic</subject><subject>Blood platelets</subject><subject>Blood tests</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cefepime - adverse effects</subject><subject>Creatinine</subject><subject>Female</subject><subject>Hepatitis</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Laboratories</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Platelet Count</subject><subject>Thrombocytopenia</subject><subject>Thrombocytopenia - chemically induced</subject><subject>Thrombosis</subject><subject>Urinary Tract Infections</subject><issn>1757-790X</issn><issn>1757-790X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkM1Lw0AQxRdRbKk9e5OAV2N3M5vdrAdBil9Q8KLgbdlsZm1Kk42bpND_3pRWqXOZgXnz5vEj5JLRW8ZAzHIb4oQmLE44SK5OyJjJVMZS0c_To3lEpm27okMB4xmHczKClIICkGNyM0eHTVnhXWSi2m9wHVnTtxh5F3XL4Kvc223nG4N1aS7ImTPrFqeHPiEfT4_v85d48fb8On9YxBYy2sXgUDlEVIlEV9g0lanNmEJ0UCjIJSJD5IlFyqzlNi1EIkBQyllmlS0oTMj93rfp8woLi3UXzFo3oaxM2GpvSv1_U5dL_eU3OpNCKsEHg-uDQfDfPbadXvk-1ENmnYgBGU8zKgbVbK-ywbdtQPf3gVG9I6wHwnpHWO8JDxdXx8H-9L884Qfqk3en</recordid><startdate>20220117</startdate><enddate>20220117</enddate><creator>Muhammad, Shoaib</creator><creator>Ahmad, Soban</creator><creator>Khan, Behram Ahmed</creator><creator>Yousaf, Amman</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0646-508X</orcidid></search><sort><creationdate>20220117</creationdate><title>Cefepime: a novel cause of thrombocytopaenia</title><author>Muhammad, Shoaib ; Ahmad, Soban ; Khan, Behram Ahmed ; Yousaf, Amman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-3fe9feee927efdc5575c819eef3d93b7ee1ee42ce01cc4c5d6263600418c9cd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Antibiotics</topic><topic>Antibodies</topic><topic>Asymptomatic</topic><topic>Blood platelets</topic><topic>Blood tests</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cefepime - adverse effects</topic><topic>Creatinine</topic><topic>Female</topic><topic>Hepatitis</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Laboratories</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Platelet Count</topic><topic>Thrombocytopenia</topic><topic>Thrombocytopenia - chemically induced</topic><topic>Thrombosis</topic><topic>Urinary Tract Infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muhammad, Shoaib</creatorcontrib><creatorcontrib>Ahmad, Soban</creatorcontrib><creatorcontrib>Khan, Behram Ahmed</creatorcontrib><creatorcontrib>Yousaf, Amman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muhammad, Shoaib</au><au>Ahmad, Soban</au><au>Khan, Behram Ahmed</au><au>Yousaf, Amman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cefepime: a novel cause of thrombocytopaenia</atitle><jtitle>BMJ case reports</jtitle><addtitle>BMJ Case Rep</addtitle><date>2022-01-17</date><risdate>2022</risdate><volume>15</volume><issue>1</issue><spage>e243749</spage><pages>e243749-</pages><issn>1757-790X</issn><eissn>1757-790X</eissn><abstract>Thrombocytopaenia is a commonly encountered finding in hospitalised patients. Many antibiotics, especially beta-lactams, are well known to cause thrombocytopaenia by an immune-mediated mechanism. We present a 55-year-old woman who was admitted to the hospital with a complicated urinary tract infection resulting in right-sided pyonephrosis and pararenal abscess. She was observed to develop thrombocytopaenia after initiation of cefepime therapy. Following an extensive work-up for her new-onset thrombocytopaenia, she was diagnosed as a case of a drug (cefepime)-induced thrombocytopaenia. Her platelet count recovered back to normal levels after cessation of cefepime therapy. Based on our PubMed search, there are only a few cases of cefepime-induced thrombocytopaenia published in the literature. This paper illustrates that physicians should include cefepime among the possible aetiologies of thrombocytopaenia. Additionally, this article outlines the currently available approaches to the diagnosis and management of drug-induced thrombocytopaenia.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>35039337</pmid><doi>10.1136/bcr-2021-243749</doi><orcidid>https://orcid.org/0000-0003-0646-508X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1757-790X
ispartof BMJ case reports, 2022-01, Vol.15 (1), p.e243749
issn 1757-790X
1757-790X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8767964
source PubMed (Medline)
subjects Anti-Bacterial Agents - adverse effects
Antibiotics
Antibodies
Asymptomatic
Blood platelets
Blood tests
Case Report
Case reports
Cefepime - adverse effects
Creatinine
Female
Hepatitis
HIV
Human immunodeficiency virus
Humans
Laboratories
Middle Aged
Patients
Platelet Count
Thrombocytopenia
Thrombocytopenia - chemically induced
Thrombosis
Urinary Tract Infections
title Cefepime: a novel cause of thrombocytopaenia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T09%3A09%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cefepime:%20a%20novel%20cause%20of%20thrombocytopaenia&rft.jtitle=BMJ%20case%20reports&rft.au=Muhammad,%20Shoaib&rft.date=2022-01-17&rft.volume=15&rft.issue=1&rft.spage=e243749&rft.pages=e243749-&rft.issn=1757-790X&rft.eissn=1757-790X&rft_id=info:doi/10.1136/bcr-2021-243749&rft_dat=%3Cproquest_pubme%3E2620245806%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c380t-3fe9feee927efdc5575c819eef3d93b7ee1ee42ce01cc4c5d6263600418c9cd03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2620245806&rft_id=info:pmid/35039337&rfr_iscdi=true